This inventor holds 1 USPTO granted patent and 3 published patent applications and 1 EPO patent. Top assignee: Sanofi. Active years: 2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2025
Title: Bodo Brunner: Innovator in RNA Therapeutics
Introduction
Bodo Brunner is a notable inventor based in Frankfurt, Germany. He has made significant contributions to the field of RNA therapeutics, particularly in the development of methods for inhibiting gene expression.
Latest Patents
Bodo Brunner holds a patent for RNA compositions and methods for inhibiting ANGPTL8. This patent focuses on double-stranded RNAs (dsRNAs) that target ANGPTL8, outlining methods to inhibit ANGPTL8 gene expression and treat conditions associated with this gene.
Career Highlights
Throughout his career, Bodo has worked with prominent companies in the pharmaceutical industry, including Sanofi and Sanofi-Aventis Deutschland GmbH. His work has been instrumental in advancing therapeutic strategies that leverage RNA technology.
Collaborations
Bodo has collaborated with esteemed colleagues such as Christiane Metz-Weidmann and Pierrick Rival. These partnerships have contributed to the innovative research and development in his field.
Conclusion
Bodo Brunner's work in RNA compositions and gene expression inhibition showcases his commitment to advancing medical science. His contributions are paving the way for new therapeutic approaches in treating conditions linked to ANGPTL8.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile